News BriefsScience & Research

Report: Psychedelics Could Prove Too Subjective for Pharmaceutical Formulas

A paper, โ€œThe shifting fortunes of corporate psychedelia,โ€ published in the September issue of Cambridgeโ€™s Finance and Society, suggests that the โ€œunruliness [of] psychedelics as assetsโ€ could severely limit the capitalization of for-profit psychedelic medicines. Published by Dr. Sandy Brian Hager, Reader in International Political Economy at City St Georgeโ€™s, University of London, the research […]